Literature DB >> 18160941

Hysterectomy surveillance in the United States, 1997 through 2005.

Ray M Merrill1.   

Abstract

BACKGROUND: To identify patterns and trends in hysterectomy from 1997 through 2005. MATERIAL/
METHODS: Analyses are based on hysterectomy prevalence data from the Behavior Risk Factor Surveillance System, hysterectomy incidence data from the National Hospital Discharge Survey, and population estimates from the US Census Bureau.
RESULTS: Hysterectomy rates significantly decreased 1.9% per year between 1997 and 2005 (-0.5% for ages 18-44, -3.1% for ages 45-64, and -5.0% for ages 65 years and older). The estimated annual decrease in rates was significant in the Northeast (-2.9%), Northwest (-1.7%), and South (-2.6%), but not in the West. For hysterectomies performed among women ages 18-44 years, the percentage in 1997-98 compared with 2004-05 resulting from leiomyoma (fibroids) decreased (31.4% vs. 26.9%), from uterine bleeding increased (14.6% vs. 25.2%), from endometriosis decreased (17.3% in vs. 16.2%), and from pain increased (10.4% vs. 11.7%); the most common procedure, total abdominal hysterectomy, decreased (65.0% vs. 60.5%), the second most common procedure, vaginal hysterectomy, decreased (32.0% vs. 30.7%), and the third most common procedure, subtotal hysterectomy, increased (1.6% in 1997-98 and 7.5% in 2004-05). Decreases in hysterectomy rates occurred for most of the reproductive health conditions resulting in hysterectomy. Exceptions included pain and bleeding in the age group 18-44 and bleeding in the age group 45-64. An increase occurred in subtotal abdominal hysterectomy rates in each of the age groups.
CONCLUSIONS: Continued monitoring of hysterectomy rates provides an indication of female reproductive health and how women are being treated for selected reproductive problems.

Entities:  

Mesh:

Year:  2008        PMID: 18160941

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  91 in total

1.  Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.

Authors:  Desireé M McCarthy-Keith; Minnie Malik; Joy Britten; James Segars; William H Catherino
Journal:  Fertil Steril       Date:  2011-04-15       Impact factor: 7.329

Review 2.  [Imaging before and after uterine artery embolization].

Authors:  T J Kröncke
Journal:  Radiologe       Date:  2008-07       Impact factor: 0.635

3.  Reassessing hysterectomy.

Authors:  Elizabeth A Stewart; Lynne T Shuster; Walter A Rocca
Journal:  Minn Med       Date:  2012-03

4.  Roles of Health Care Providers and Patients in Initiation of Unnecessary Papanicolaou Testing After Total Hysterectomy.

Authors:  Fangjian Guo; Yong-Fang Kuo
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

5.  Analysis of postoperative pain in robotic versus traditional laparoscopic hysterectomy.

Authors:  Raymond E Betcher; James P Chaney; Pamela R Lacy; Stephen K Otey; Duke J Wood
Journal:  J Robot Surg       Date:  2013-07-03

6.  Postmenopausal Symptoms in Female Veterans with Type 2 Diabetes: Glucose Control and Symptom Severity.

Authors:  Patricia A Rouen; Sarah L Krein; Nancy E Reame
Journal:  J Womens Health (Larchmt)       Date:  2015-05-04       Impact factor: 2.681

7.  Suboptimal rates of cervical testing among women with inflammatory bowel disease.

Authors:  Millie D Long; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-15       Impact factor: 11.382

8.  Transvaginal uterosacral ligament hysteropexy: a retrospective feasibility study.

Authors:  Rodolfo Milani; Matteo Frigerio; Stefano Manodoro; Alice Cola; Federico Spelzini
Journal:  Int Urogynecol J       Date:  2016-05-19       Impact factor: 2.894

9.  Long-term outcomes following laparoscopic and abdominal supracervical hysterectomies.

Authors:  Marit Lieng; Annwe Birthe Lømo; Erik Qvigstad
Journal:  Obstet Gynecol Int       Date:  2010-03-14

10.  The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors:  Patrick O Brown; Chana Palmer
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.